PROBLEM TO BE SOLVED: To provide an anticancer agent sensitivity-determining marker that allows for determining treatment responsiveness of individual patients, and to provide novel means of treating cancer using the same.SOLUTION: An anticancer agent sensitivity-determining marker comprises N-acetyl glucosamine, a substance on an amino acid metabolic pathway, a substance on a nucleic acid metabolic pathway, a substance on a pentose phosphate pathway, a glycolytic substance, a substance in the TCA cycle, a substance on a polyamine metabolic pathway, and one or more substances selected from a group of lauric acid, 6-phosphogluconic acid, butyric acid, 4-methylpyrazole, isobutylamine, glycolic acid, NADH, NAD+, and substances on metabolic pathways associated with afore mentioned substances.SELECTED DRAWING: NoneCOPYRIGHT: (C)2016,JPO&INPIT【課題】個々の患者の治療反応性を判別できる抗がん剤感受性判定マーカー及びそれを利用する新たながん治療手段を提供する。【解決手段】Ｎ－アセチルグルコサミン、アミノ酸代謝系上の物質、核酸代謝系上の物質、ペントースリン酸経路上の物質、解糖系上の物質、ＴＣＡ回路上の物質、ポリアミン代謝系上の物質並びにＬａｕｒｉｃ ａｃｉｄ、６－Ｐｈｏｓｐｈｏｇｌｕｃｏｎｉｃ ａｃｉｄ、Ｂｕｔｙｒｉｃ ａｃｉｄ、４－Ｍｅｔｈｙｌｐｙｒａｚｏｌｅ、Ｉｓｏｂｕｔｙｌａｍｉｎｅ、Ｇｌｙｃｏｌｉｃ ａｃｉｄ、ＮＡＤＨ、ＮＡＤ＋及びそれらの物質が関与する代謝系上の物質から選ばれる１以上の物質からなる、抗がん剤感受性判定マーカー。【選択図】なし
